Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

A group of researchers recently conducted a clinical study to provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies (CIPN) in adult cancer survivors.  READ MORE

Source: Journal of Oncology

Join us in improving the lives of peripheral neuropathy patients.
Send this to a friend